The gene coding for protein A (spa) of Staphylococcus aureus 8325-4 has been inactivated by substituting part of the spa coding sequence for a DNA fragment specifying resistance to ethidium bromide. The in vitroconstructed spa::EtBrr substitution mutation was introduced into the S. aureus chromosome by recombinational allele replacement. Southern blot hybridization showed that the in vitro-constructed mutation was present in the chromosomal spa locus. We have previously reported the inactivation of the alpha-toxin gene (hly) by allele replacement with an in vitro-constructed hly::Emr (erythromycin resistance) mutation (M. O'Reilly, J. C. S. de Azavedo, S. Kennedy, and T. J. Foster, Microb. Pathogen. 1:125-138, 1986 Staphylococcus aureus is a pathogenic bacterium which causes a variety of infections in humans, including endocarditis, osteomyelitis, wound sepsis, skin abcesses, and the economically important disease of dairy cattle, mastitis (for a review, see reference 12). The organism can produce an array of potential virulence factors, such as alpha-, beta-, gamma-and delta-toxins, leucocidin, coagulase, and protein A. However, apart from alpha-lysin (1, 20, 46) and coagulase (20), direct evidence that any of these factors is required for the pathogenesis of staphylococcal infections is lacking.
virulence factor of S. aureus.
Staphylococcus aureus is a pathogenic bacterium which causes a variety of infections in humans, including endocarditis, osteomyelitis, wound sepsis, skin abcesses, and the economically important disease of dairy cattle, mastitis (for a review, see reference 12). The organism can produce an array of potential virulence factors, such as alpha-, beta-, gamma-and delta-toxins, leucocidin, coagulase, and protein A. However, apart from alpha-lysin (1, 20, 46) and coagulase (20) , direct evidence that any of these factors is required for the pathogenesis of staphylococcal infections is lacking.
Protein A is a cell wall-associated protein of S. aureus (14, 15, 23, 40) . It has the unusual property of binding to the Fc region of immunoglobulins from different mammalian species. Molecular cloning and DNA sequencing have shown that protein A from strain 8325-4 is composed of five repeated units, each of which is an immunoglobulin G (IgG)-binding domain (25, 28, 43) . In addition, the carboxyterminal region is required for the linkage of protein A to the cell envelope of S. aureus (15) .
Protein A is synthesized mainly in the logarithmic phase of growth (4, 29) . In contrast, many other exoproteins (e.g., alpha-toxin) are expressed predominantly during the stationary phase of growth (4, 32, 33, 35, 36) . There is evidence that the protein A gene is controlled negatively and that alphatoxin is controlled positively, possibly at the transcriptional level, by a regulatory gene called agr (4, 15, 30, 35, 36, 44) .
It is probable that protein A has a role in the pathogenesis of staphylococcal infections. It produces a variety of biological effects when administered to laboratory animals or when tested in vitro (14, 23) . These include hypersensitivity reactions, release of histamine from basophils, activation of complement, and derepression of the opsonizing activity of serum. One approach to establishing the importance of such a factor in virulence is to examine the ability of mutants to cause experimental infections (42) . However, previous vir-* Corresponding author.
ulence studies with protein A-deficient mutants isolated by chemical mutagenesis have given ambiguous results (20, 45) .
To assess the relevance of protein A in virulence and to avoid the problems of chemical mutagenesis, we have isolated a protein A-deficient mutant of S. aureus 8325-4 by allele replacement site-directed mutagenesis. The virulence of this mutant and a previously isolated mutant deficient in alpha-toxin (32) was tested in experimental infections of mice.
MATERIALS AND METHODS
Bacterial strains, plasmids, and bacteriophages. The bacterial strains are shown in Table 1, and the plasmids are shown  in Table 2 . The replacement vector XL47.1 (24) was used to clone the spa gene. The staphylococcal phages 80a and 85, which were used to transduce plasmids and chromosomal markers, respectively, were obtained from H. Pomeroy (Microbiology Department, Trinity College, Dublin) as was the lysogenic converting phage 42E. S. aureus strains were lysogenized with phage 42E as described previously (32) and consequently lost the ability to produce beta-toxin (9, 48 Bacteriological media. Escherichia coli strains were grown in L broth and L agar (11, 30) , whereas S. aureus was routinely cultured in Trypticase soy broth and agar (BBL Microbiology Systems, Cockeysville, Md.), and peptone water (Oxoid Ltd., London, England) was used for resuspending cells before inoculation. A phages were propagated in X base and top agar (11, 27) . Bernheimer-Schwartz broth (3) was used for culturing S. aureus for measuring the 3104 PATEL ET AL. 5-bromo-4-chloro-3-indolyl-,3-D-galactopyranoside tected as described previously (18) . Proteins were subjected (X-Gal), and cetyltrimethylammonium bromide (CTAB) to sodium dodecyl sulfate-polyacrylamide gel electrophorewere purchased from Sigma. Restriction enzymes and T4 sis (22) and analyzed by Western immunoblotting (6 (26) and into protoplasts of S. aureus (8, 13, 32) . loaded with 20 ,ul of culture supernatant and incubated at Plaque and colony immunoblotting. X plaques producing 37°C for 18 h. Coagulase expression was tested by mixing protein A were detected by laying 82-mm-diameter nitrocelculture supernatants (0.75 ml) with 0.25 ml of neat rabbit lulose disks (Schleicher & Schuell, Inc., Keene, N.H.) onto plasma and incubating for 18 h at 37°C. phage overlay plates. The filters were incubated succes-MIC determinations. Narrow-interval MIC determinations (33) , except that the genomic DNA was cleaved with Sau3AI and the A replacement vector was cut with BamHI. Subcloning and restriction mapping experiments were carried out by standard procedures (26) . DNA probes were labeled by nick translation in vitro (26) with 20 ,uCi of [oc-32P]dATP (Amersham Corp., Bucks, United Kingdom). Southern blot hybridization (41) was carried out as described previously (26) .
Construction of pEC1. About 1 ,ug of a 1.14-kilobase (kb) TaqI fragment carrying the origin of replication of plasmid pE194 (17) was ligated with an equal amount of a 1.16-kb TaqI fragment carrying the Cmr determinant of pC221 (5) . Cmr transformants of S. aureus RN4220 were isolated, and one was shown to have the desired structure.
Construction of the Aspa::EtBrr mutation in vitro. Samples (20 ,ug) of pSPA721 DNA were cleaved with PstI and Bcll, then separately cleaved with BclI and EcoRI, and fractionated on 1.2% agarose gels. A 0.6-kb PstI-BclI fragment and a 0.9-kb BclI-EcoRI fragment were isolated from the gels by electroelution (26) , ligated with 0.5 jig of PstI-and EcoRIcleaved pUC18 DNA, and transformed into E. coli TB1. White colonies appearing on L agar plates incorporating ampicillin (100 ,ug/ml) and X-Gal were screened for plasmids carrying both fragments. One plasmid with the Aspa mutation (pEBP962; Fig. 1 ) was kept for further study. A BglII fragment from pCW59-Ebr, which expresses resistance to EtBr (19) was introduced into the Bcll site of pEBP962 to form pEBM1 and create the Aspa::EtBrr mutation (Fig. 1 ). Recombinants were detected by replica plating Apr transformants onto agar incorporating EtBr (1,000 ,Ig/ml). A shuttle plasmid (pEBM15; Fig. 1 (Fig. 1) . A restriction map of this EcoRI fragment (Fig. 1 ) agreed with those published by Lofdahl et al. (25) and Uhlen et al. (43) .
Isolation of a Aspa::EtBr' mutation. Spa-mutants of S. aureus 8325-4 were isolated by allele replacement sitedirected mutagenesis by using a strategy first used in this organism by O'Reilly et al. (32) for isolating mutations de'fective in alpha-toxin. A 1.2-kb BclI fragment which is internal to the spa gene and which codes for the five IgG-binding domains and part of the cell wall attachment region of the protein (15, 25, 28, 43) was deleted from pSPA721 in vitro. Then a 2-kb BglII fragment carrying an EtBrr determinant from pCW59-Ebr which specifies lowlevel resistance to EtBr and CTAB (Table 3) was inserted into the Bcll site of pEBP962 to form the Aspa::EtBrr mutation on plasmid pEBM1 (Fig. 1) . A shuttle plasmid (pEBM15 EtBrr Emr Apr) was constructed ( Fig. 1) and transferred into S. aureus 8325-4, along with an incompatible plasmid pECI (Cmr).
After growth for 200 generations in broth containing chloramphenicol (to maintain selection for pEC1), the .spa::EtBrr plasmid pEBMiS had been completely eliminated from the population. Cells were plated on EtBr and CTAB agar, and the resultant colonies were tested for Spa production on dog serum agar. It should be noted that control experiments showed that spontaneous EtBrr and CTABr mutants of S. aureus arose at a frequency of about 5 X 10-5. DNA dot-blot hybridization was used to identify the desired recombinants with the Bcll fragment from within spa (no hybridization) and the 2-kb BglII fragment of pCW59-Ebr (positive hybridization) as probes. One mutant, DU5723, was kept for further analysis.
Several spontaneous EtBrr and CTABr mutants were purified, and the resistance of these mutants to EtBr and CTAB compared with those of a strain harboring pEBM15 (which carries the EtBrr determinant from pCW59-Ebr) and the chromosomal spa::EtBrr recombinant ( Table 3 ). The plasmid-derived EtBrr determinant expressed a lower level of resistance to both EtBr and'CTAB when it was integrated in the spa locus in the chromosome. The spontaneous mutants exhibited a variety of resistance phenotypes. Generally, the mutants selected on CTAB expressed cross resistance to EtBr, whereas those selected on EtBr were not resistant to CTAB. The levels of EtBrr and CTABr were higher than that expressed by the spa::EtBrr recombinant. 2) , the 2-kb BglII fragment from pCW59-Ebr (lanes 3 and 4) , and the EcoRI fragment carrying spa' from pSPA721 (lanes 5 and 6).
Characterization of S. aureus 8325-4Aspa::EtBrr. Southern blot hybridization was performed to verify that the Spamutant had the predicted structural changes in the spa locus.
Chromosomal DNA from the mutant and the parental Spa' strain was cleaved with EcoRI and' probed with the 1.2-kb BclI fragment (which is intragenic to spa), the 2-kb BglII fragment (which carries the inserted EtBrr determinant), and the 4.3-kb EcoRI fragment from pSPA721 (which contains the intact spa gene).
A 4.3-kb fragment in 8325-4 hybridized when chromosomal DNA cleaved with EcoRI was probed with the 1.2-kb BclI fragment from the spa gene (Fig. 2, lane 2) , whereas the mutant failed to hybridize (Fig. 2, lane 1) . In contrast, probing with the inserted 2-kb BglII fragment revealed a 5.1-kb EcoRI fragment in mutant strain DU5723, whereas the parental strain failed to hybridize (Fig. 2, lane's 3 and 4) . A fragment of 5.1 kb in the mutant also hybridized to the 4.3-kb spa'probe (Fig. 2, lane 5) , whereas the homologous fragment hybridized in the wild-type strain (Fig. 2, lane 6) . This data is consistent with the Spa-phenotype being caused by recombination of the in vitro-constructed Aspa::EtBrr mutation into the genome of 8325-4 in place of the wild-type spa allele.
Western blot analysis showed that the mutant strain DU5723 lacked detectable protein A (Fig. 3, lanes 1 and 2) , whereas the parental strain 8325-4 expressed both cell-free and cell wall-bound forms (Fig. 3, lanes 3 and'4) .
The mutant strain produced similar levels of alpha-, beta-, delta-, and gamma toxins and coagulase, lipase, and DNase as the parental strain (data not shown). Furthermore, the strains had identical phage susceptibility patterns. Thus, the Spa-mutant does not appear to be pleiotropic. 2) were analyzed. Protein in cell walls (lanes 1 and 3) and in culture supernatants (lanes 2 and 4) was extracted and fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto nitrocellulose. Filters were incubated with rabbit anti-protein A antibodies and then with peroxidase-conjugated swine anti-rabbit IgG serum. Proteins of known molecular weight (in thousands) are indicated.
hly::Emr locus was transduced from strain DU1090 into strain DU5723 to construct the doubly defective mutant strain DU5724. Before use in virulence tests, the strains were cured of plasmids and then lysogenized with phage 42E which prevents expression of beta-hemolysin by insertion into the hlb gene (9) . The latter manipulation was performed to allow our results to be compared with those of Jonsson et al. (20) , who used strain SA113, a derivative of strain 8325 which is lysogenic for the staphylokinase converting phage .413 and which consequently does not produce beta-toxin.
Virulence tests with S. aureus mutants. Female Sha Sha mice were injected subcutaneously with strains DU5719, DU5720, DU5721, and DU5722. Lesions were examined after 24 h. The mice were sacrificed, and the area of the lesions was measured. Tissue sections were examined histologically.
Strains which produce alpha-toxin caused a raised, cream lesion with an outer reddened area (Fig. 4) . In contrast, alpha-toxin-negative strains caused a lesion which had a blackened, sunken center (Fig. 4) . This was surrounded by a raised, cream zone and an outer, reddened area. Microscopic examination of stained sections of infected areas revealed an acute seropurulent inflammatory reaction. In mice infected with the Hly+ strain, DU5719 neutrophil infiltration is confined mainly to the periphery of the lesion (Fig. SA.) Few neutrophils are present in the center and are rarely seen in close contact with bacterial cells. In mice infected with the Hly-strain, DU5720, neutrophils are present in large numbers (Fig. 5B) . The region containing bacteria is surrounded by neutrophils, a high proportion of which are necrotic.
The alpha-toxin-producing strains were at least 10-fold more virulent than those which lacked the toxin. mm2 (Table 4) . A similar effect was seen when the Hly+ Spa-strain DU5721 was compared with the Hly-Spastrain DU5722 (Table 4) . This shows that alpha-toxin is a major determinant of subcutaneous abscesses in mice. The data ( Table 4 ) also suggest that protein A contributes to the size of the lesions caused by both Hly+ and Hlystrains. The differences between Spa' and Spa-strains were less pronounced than those seen with alpha-toxin. The absence of Spa did not affect the nature of the lesion, only its size.
The virulence of the mutant strains was also assessed by measuring the survival of Laca mice injected intraperitoneally. At least fourfold more Hly-bacteria were required to kill mice at the same rate as the otherwise isogenic Hly+ strains (Table 5 ). This result was obtained with both the Spa' and Spa-strains. In addition, the Spa-mutants were marginally but reproducibly less virulent than their Spa' counterparts, although some of the comparisons were not significant at the 5% level (Table 5) .
To confirm this result, pools of 12 mice were injected (32) . However, the EtBrr marker was not ideal for this purpose, because the resistance level was reduced substantially when the determinant was integrated in the chromosome, possibly due to a reduction in (34) . Previous virulence studies with alpha-toxin mutants isolated by allele replacement suggested that the toxin contributed to the virulence of S. aureus in mice (32), an observation which we have confirmed here with subcutaneous and peritonitis infections. This is not surprising because alphatoxin is a potent exotoxin of S. aureus and has been strongly implicated as a virulence factor by other studies (1, 20, 46) .
In addition to the quantitative differences in virulence between Hly+ and Hly-strains measured in the subcutaneous infections, the lesions obtained were substantially different both superficially (Fig. 4) and histologically (Fig. 5) . The absence of neutrophils in the vicinity of bacteria in lesions caused by Hly+ strains is consistent with the observation that purified alpha-toxin inhibits neutrophil chemotaxis in vitro (37) .
We also demonstrate that protein A makes a contribution to both types of infection. Spa-mutants formed smaller skin lesions than their Spa' counterparts, as well as being slightly less virulent when injected intraperitoneally. It will be interesting to test our mutants in other experimental infections of mice and other animal species and also to examine the ability of the mutant bacteria to grow in diffusion chambers or in granuloma pouches.
These results contradict a previous report that most Spamutants of strain SA113 were not less virulent for mice (20) . One Spa-mutant which did have lowered virulence was subsequently also shown to be deficient in a protein that binds fibronectin (45) . Our finding that Spa appears to be a virulence factor for staphylococcal infections of mice could be due to the use of different animal models or to differences between the bacterial strains used.
Although allele replacement is the most satisfactory method for isolating mutations affecting virulence, some degree of caution must be exercised when interpreting virulence experiments. First, the drug resistance insert might affect the expression of other genes due to polarity. This is unlikely for spa, since the gene is flanked by sequences resembling transcription terminators (43) , suggesting that it is monocistronic. However, it is not known if hly is monocistronic or if it is expressed as part of a larger transcription unit.
Second, it is conceivable that the inserted drug resistance marker is responsible for the reduction in virulence. The best way to control for this is to isolate a deletion in the chromosomal gene. However, attempts to isolate a deletion in hly by allele replacement by using colony hybridization to detect the recombinant have failed, possibly due to the low frequency of this type of recombination event (ca. 10-7, unpub- lished data). Virulence could be measured in a strain carrying the resistance marker on a plasmid, but controls would have to be performed to ensure that the plasmid was not interfering with virulence.
Finally, it is possible that the small reduction in virulence of Spa-mutants is not directly due to loss of protein A expression but to a slower growth rate. We have measured the doubling times of the four strains during early exponential growth and no significant differences were found (unpublished data).
